VAM 20 1510: JACI: In Practice Year-in-Review Workshop

Session 1510 includes the following talks:

  • Asthma
  • Food Allergy and Anaphylaxis
  • Drug Allergy and Urticaria/Angioedema

The American Board of Allergy and Immunology (ABAI) has approved this activity for 1.25 MOC Part ll Self-Assessment credits.  These credits will be awarded once you have completed all components of the course.  

Target Audience

  • Physicians
  • Allergist/Immunologists
  • Nurses
  • Nurse Practitioners
  • Allied Health Professionals

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify the findings from recent clinical research in the areas of asthma, food allergy, anaphylaxis, drug allergy, and urticaria/angioedema
  • Identify the strengths, limitations, and practical implications of the highlighted studies
  • Identify options to apply these findings to the management of patients with asthma, food allergy, anaphylaxis, drug allergy, and urticaria/angioedema
Available credit: 
  • 1.25 Attendance
    Attendance credit.
  • 1.25 CME
    CME credit.
Course opens: 
Course expires: 
Planning Committee

See attachment at bottom of page for Annual Meeting Planning Committee disclosure information.


Robert Zeiger, MD PhD FAAAAI
Kaiser Permanente Southern California, San Diego, CA
Relevant relationships: AstraZeneca, DBV Technologies, GSK, Merck, Novartis, SanofiRegeneron (consultant); DBV Technologies (other)

Scott Sicherer, MD FAAAAI
Mt. Sinai School of Medicine, New York, NY
Relevant relationships: None

David Khan, MD FAAAAI
University of Texas Southwestern, Dallas, TX
Relevant relationships: None

COI Reviewers

Edwin Kim, MD
University of North Carolina, Chapel Hill, NC
Relevant relationships: DBV Technologies, Aimmune: food allergy oral immunotherapy

Accreditation Statement

The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE Designation Statement

The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 1.25 Contact Hours.

Credit Claiming Period

Credit claiming for this activity will expire at 11:59 pm on May 31, 2022. Requests to claim credit on or after June 1, 2022 will be subject to an administrative fee.

AAAAI Privacy Policy

To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at


Activity related questions should be directed to

Available Credit

  • 1.25 Attendance
    Attendance credit.
  • 1.25 CME
    CME credit.


Please login or register to take this course.

Required Hardware/software

One of the two most recent versions of Chrome, Firefox, or Safari.

Internet Explorer is no longer supported.